At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC) therapy in ...

In the last decade, the growing disparity between declining professional fee CPT reimbursements and hospital-based contracting has led more orthopedists to choose hospital employment or practice ...